Vivifi Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 01-01-2025
- Paid Up Capital ₹ 0.10 M
as on 01-01-2025
- Company Age 13 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 01-01-2025
- Revenue 24.64%
(FY 2022)
- Profit 23.93%
(FY 2022)
- Ebitda -6.31%
(FY 2022)
- Net Worth 27.76%
(FY 2022)
- Total Assets 2.60%
(FY 2022)
About Vivifi Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Arun James, Mohanannair Manojmohan, Radha Soman, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239KL2012PTC030325
- Company No.
030325
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vivifi Life Sciences Private Limited offer?
Vivifi Life Sciences Private Limited offers a wide range of products and services, including Metformin Tablets, Glimepiride Metformin Tablet, Blood Pressure Medicine, Telmisartan Tablets, API (Active Pharmaceutical Ingredients), Vitamin Tablets & Capsules, Methylcobalamin Tablets.
Who are the key members and board of directors at Vivifi Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Radha Soman  | Managing Director | 15-Oct-2016 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arun James | Director | 20-Jan-2012 | Current |
| Mohanannair Manojmohan | Director | 15-Oct-2016 | Current |
| Umaran Sujith | Director | 24-Jun-2019 | Current |
| Padmakumar Reghunathan | Additional Director | 24-Jun-2019 | Current |
Financial Performance of Vivifi Life Sciences.
Vivifi Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 24.64% increase. The company also saw a substantial improvement in profitability, with a 23.93% increase in profit. The company's net worth Soared by an impressive increase of 27.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vivifi Life Sciences?
Unlock access to Vivifi Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2024 | Others | ₹2.00 Cr | Open |
How Many Employees Work at Vivifi Life Sciences?
Vivifi Life Sciences has a workforce of 22 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vivifi Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivifi Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
